Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ML347 (LDN 193719)(DN193719) is a highly specific ALK1/2 inhibitor ( IC50: 46/32 nM), and the selectivity for ALK2 is <300-fold than ALK3.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 33.00 | |
5 mg | In stock | $ 52.00 | |
10 mg | In stock | $ 77.00 | |
25 mg | In stock | $ 159.00 | |
50 mg | In stock | $ 288.00 | |
100 mg | In stock | $ 490.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 57.00 |
Description | ML347 (LDN 193719)(DN193719) is a highly specific ALK1/2 inhibitor ( IC50: 46/32 nM), and the selectivity for ALK2 is >300-fold than ALK3. |
Targets&IC50 | ALK1:46 nM, ALK2:32 nM |
In vivo | In both human and rat plasma, ML347 exhibits high binding affinity with plasma proteins. Additionally, ML347 demonstrates significant efficacy in C2C12BRA cells responsive to BMP signaling, evidenced by an IC50 value of 15 nM. |
Kinase Assay | Kinase assay: All kinase assays are conducted by Reaction Biology Corp. In brief, compounds are tested at 10 concentrations by 3-fold serial dilutions starting at 30 μM, using nonspecific kinase inhibitor staurosporine as control. In vitro kinase reactions are carried out in the presence of 10 μM (33P)γATP. Five kinases tested are the human BMP type-I receptor activin receptor-like kinase 2 (ALK-2/ACVR1), the human TGFβ type-I receptor activin receptor-like kinase 5 (Alk5/TGFβR1), the human VEGF type-II receptor (KDR/Flk-1/VEGFR2), the human AMP-activated protein kinase (AMPK/A1/B1/G1) and the human platelet-derived growth factor receptor-β (PDGFRβ). |
Synonyms | LDN 193719 |
Molecular Weight | 352.39 |
Formula | C22H16N4O |
CAS No. | 1062368-49-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 7.1 mg/mL (20 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ML347 1062368-49-3 Angiogenesis Stem Cells Tyrosine Kinase/Adaptors ALK TGF-beta/Smad Inhibitor Smad1/5 inhibit LDN 193719 LDN-193719 LDN193719 TGF-β Receptor ML 347 Transforming growth factor beta receptors ALK1 ML-347 ALK2 inhibitor